La Fundaction Para la Investigacion Biomedica, Madrid, Spain Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2008
NCT00530127
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now